Farallon Capital Management 13F holdings, Q4 2018
Holdings as of December 31, 2018 · filings on SEC EDGAR · latest filing →
Farallon Capital Management disclosed 94 US equity positions worth $11.4bn in its Q4 2018 13F filing. The largest position was ALTABA INC at 14.0% of the reported book, followed by TWENTY FIRST CENTY FOX INC and GOOG. Against the Q3 2018 filing, it opened 7 new positions, added to 33 and reduced 8 among the top 50 holdings.
What did Farallon Capital Management own in Q4 2018? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2018 |
|---|---|---|---|---|---|---|---|
| 1 | ALTABA INC | 14.0% | $1.6bn | 27,607,317 | 30% | added | |
| 2 | TWENTY FIRST CENTY FOX INC | 5.4% | $615.6m | 12,792,300 | 791% | added | |
| 3 | GOOG ALPHABET INC | Communication Services | 4.2% | $480.9m | 464,405 | 48% | added |
| 4 | RED HAT INC | 4.1% | $471.6m | 2,685,000 | – | new | |
| 5 | META FACEBOOK INC | Communication Services | 3.5% | $400.0m | 3,051,148 | 23% | added |
| 6 | EQIX EQUINIX INC | Real Estate | 3.4% | $391.7m | 1,110,892 | 83% | added |
| 7 | WAB WABTEC CORP | Industrials | 3.4% | $388.6m | 5,531,059 | 58% | added |
| 8 | IQV IQVIA HLDGS INC | Healthcare | 3.3% | $374.0m | 3,219,308 | 6% | added |
| 9 | TWENTY FIRST CENTY FOX INC | 3.2% | $370.1m | 7,745,000 | 44% | added | |
| 10 | CHTR CHARTER COMMUNICATIONS INC N | Communication Services | 2.7% | $307.9m | 1,080,481 | -9% | reduced |
| 11 | V VISA INC | Financial Services | 2.7% | $306.1m | 2,319,726 | 18% | added |
| 12 | TRU TRANSUNION | Financial Services | 2.6% | $299.3m | 5,268,739 | 54% | added |
| 13 | BKNG BOOKING HLDGS INC | Consumer Cyclical | 2.5% | $285.0m | 165,482 | 29% | added |
| 14 | IHS MARKIT LTD | 2.5% | $284.0m | 5,920,016 | 17% | added | |
| 15 | ELV ANTHEM INC | Healthcare | 2.4% | $275.8m | 1,050,000 | 1% | added |
| 16 | MSFT MICROSOFT CORP | Technology | 2.3% | $263.0m | 2,588,874 | 20% | added |
| 17 | GD GENERAL DYNAMICS CORP | Industrials | 2.2% | $256.0m | 1,628,186 | -8% | reduced |
| 18 | PLAYA HOTELS & RESORTS NV | 1.9% | $220.1m | 30,606,930 | 0% | held | |
| 19 | CI CIGNA CORP NEW | Healthcare | 1.8% | $200.4m | 1,055,000 | – | new |
| 20 | EFX EQUIFAX INC | Industrials | 1.8% | $199.8m | 2,145,594 | 163% | added |
| 21 | FIS FIDELITY NATL INFORMATION SV | Technology | 1.7% | $194.8m | 1,899,355 | -3% | reduced |
| 22 | DELL DELL TECHNOLOGIES INC | Technology | 1.5% | $174.6m | 3,572,062 | – | new |
| 23 | TLRY TILRAY INC | Healthcare | 1.4% | $162.1m | 2,479,515 | 0% | held |
| 24 | VRSK VERISK ANALYTICS INC | Industrials | 1.4% | $157.1m | 1,441,194 | 1% | added |
| 25 | CITRIX SYS INC | 1.3% | $150.4m | 1,468,234 | -19% | reduced | |
| 26 | AZN ASTRAZENECA PLC | Healthcare | 1.3% | $147.6m | 3,885,000 | 14% | added |
| 27 | BABA ALIBABA GROUP HLDG LTD | Consumer Cyclical | 1.3% | $143.9m | 1,050,000 | 182% | added |
| 28 | LIBERTY GLOBAL PLC | 1.1% | $127.5m | 5,972,437 | -10% | reduced | |
| 29 | T8S TESARO INC | 1.1% | $126.2m | 1,700,000 | – | new | |
| 30 | ARRIS INTL INC | 1.0% | $109.4m | 3,580,000 | – | new | |
| 31 | LIBERTY GLOBAL PLC | 0.9% | $101.9m | 4,937,202 | -29% | reduced | |
| 32 | ASND ASCENDIS PHARMA A S | Healthcare | 0.8% | $93.9m | 1,499,297 | 3% | added |
| 33 | XLRN ACCELERON PHARMA INC | 0.8% | $91.5m | 2,100,000 | 14% | added | |
| 34 | ARRAY BIOPHARMA INC | 0.7% | $81.9m | 5,750,000 | 12% | added | |
| 35 | MYOKARDIA INC | 0.7% | $78.2m | 1,600,278 | 5% | added | |
| 36 | ZOGENIX INC | 0.7% | $74.8m | 2,050,500 | 14% | added | |
| 37 | PANDORA MEDIA INC | 0.7% | $74.5m | 9,205,000 | – | new | |
| 38 | SRPT SAREPTA THERAPEUTICS INC | Healthcare | 0.6% | $69.8m | 640,000 | 228% | added |
| 39 | ENTA ENANTA PHARMACEUTICALS INC | Healthcare | 0.6% | $65.5m | 925,000 | 7% | added |
| 40 | CVS CVS HEALTH CORP | Healthcare | 0.5% | $60.9m | 930,000 | – | new |
| 41 | GLOBAL BLOOD THERAPEUTICS IN | 0.5% | $59.5m | 1,450,000 | 6% | added | |
| 42 | MIRATI THERAPEUTICS INC | 0.5% | $55.1m | 1,300,000 | 49% | added | |
| 43 | IOVA IOVANCE BIOTHERAPEUTICS INC | Healthcare | 0.4% | $50.7m | 5,725,000 | 21% | added |
| 44 | AMARIN CORP PLC | 0.4% | $47.6m | 3,500,000 | 6% | added | |
| 45 | GRFS GRIFOLS S A | Healthcare | 0.4% | $43.7m | 2,381,119 | 33% | added |
| 46 | NVCR NOVOCURE LTD | Healthcare | 0.4% | $41.9m | 1,250,000 | -7% | reduced |
| 47 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 0.4% | $40.1m | 550,000 | 99% | added |
| 48 | EXEL EXELIXIS INC | Healthcare | 0.3% | $39.3m | 2,000,000 | 85% | added |
| 49 | REATA PHARMACEUTICALS INC | 0.3% | $39.3m | 700,000 | 4% | added | |
| 50 | NXPI NXP SEMICONDUCTORS N V | Technology | 0.3% | $39.2m | 535,000 | -68% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.